Integral Derivatives’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Hold |
0
| – | – | – | 294 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 382 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 392 |
|
|
2017
Q2 | – | Sell |
-6,539
| Closed | -$345K | – | 374 |
|
|
2017
Q1 | $345K | Sell |
6,539
-13,695
| -68% | -$723K | 0.01% | 173 |
|
|
2016
Q4 | $974K | Buy |
+20,234
| New | +$974K | 0.02% | 90 |
|
|
2016
Q3 | – | Sell |
-4,375
| Closed | -$237K | – | 346 |
|
|
2016
Q2 | $237K | Buy |
+4,375
| New | +$237K | 0.01% | 153 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 314 |
|
|
2015
Q4 | – | Sell |
-6,055
| Closed | -$291K | – | 358 |
|
|
2015
Q3 | $291K | Buy |
6,055
+2,160
| +55% | +$104K | 0.01% | 189 |
|
|
2015
Q2 | $203K | Buy |
+3,895
| New | +$203K | 0.01% | 223 |
|
|
2015
Q1 | – | Sell |
-4,455
| Closed | -$238K | – | 405 |
|
|
2014
Q4 | $238K | Buy |
+4,455
| New | +$238K | ﹤0.01% | 265 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 482 |
|
|
2014
Q1 | – | Sell |
-25,175
| Closed | -$1.68M | – | 459 |
|
|
2013
Q4 | $1.68M | Buy |
+25,175
| New | +$1.68M | 0.02% | 92 |
|